Tonix announces collaboration to develop precision medicine techniques for Covid-19 vaccines and therapeutics

This article was originally published here

The research collaboration will focus on T cell and antibody responses to SARS-CoV-2 (CoV-2), the virus that causes COVID-19 at the cellular level including human monoclonal antibodies and

The post Tonix announces collaboration to develop precision medicine techniques for Covid-19 vaccines and therapeutics appeared first on Pharmaceutical Business review.